UnitedHealth Group (UNH) PT Lowered to $247.00 at Citigroup

Share on StockTwits

UnitedHealth Group (NYSE:UNH) had its price objective trimmed by Citigroup from $288.00 to $247.00 in a research report report published on Wednesday, BenzingaRatingsTable reports. The brokerage currently has a neutral rating on the healthcare conglomerate’s stock.

Several other equities research analysts also recently issued reports on the company. Barclays reduced their price objective on UnitedHealth Group from $290.00 to $270.00 and set an overweight rating for the company in a research note on Wednesday. Bank of America reissued a buy rating and issued a $290.00 price objective (down from $320.00) on shares of UnitedHealth Group in a research note on Wednesday. Morgan Stanley reduced their price objective on UnitedHealth Group from $315.00 to $285.00 and set an overweight rating for the company in a research note on Wednesday. Raymond James reduced their price objective on UnitedHealth Group from $310.00 to $265.00 and set a strong-buy rating for the company in a research note on Wednesday. Finally, SunTrust Banks reduced their price objective on UnitedHealth Group to $300.00 and set a buy rating for the company in a research note on Wednesday. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, one has given a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of Buy and a consensus target price of $291.56.

Shares of NYSE UNH opened at $221.75 on Wednesday. UnitedHealth Group has a 12 month low of $208.07 and a 12 month high of $287.94. The firm has a market cap of $212.78 billion, a PE ratio of 16.35, a P/E/G ratio of 1.19 and a beta of 0.79. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.73 and a quick ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 EPS for the quarter, beating the consensus estimate of $3.60 by $0.13. The business had revenue of $60.30 billion during the quarter, compared to the consensus estimate of $59.72 billion. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the business posted $3.04 earnings per share. On average, research analysts anticipate that UnitedHealth Group will post 14.7 earnings per share for the current fiscal year.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, January 22nd. The stock was sold at an average price of $266.61, for a total transaction of $1,333,050.00. Following the completion of the sale, the director now directly owns 77,702 shares of the company’s stock, valued at approximately $20,716,130.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 2,930 shares of the firm’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $253.39, for a total value of $742,432.70. Following the sale, the director now directly owns 64,726 shares of the company’s stock, valued at $16,400,921.14. The disclosure for this sale can be found here. Insiders have sold a total of 17,930 shares of company stock valued at $4,587,133 over the last ninety days. Company insiders own 0.87% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of UNH. Crewe Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at about $25,000. Pearl River Capital LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at about $35,000. Canton Hathaway LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter valued at about $36,000. Ipswich Investment Management Co. Inc. acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at about $40,000. Finally, OLD Second National Bank of Aurora increased its holdings in shares of UnitedHealth Group by 70.0% during the 4th quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock valued at $42,000 after acquiring an additional 70 shares during the last quarter. 86.68% of the stock is owned by institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: What does the Dow Jones Industrial Average (DJIA) measure?

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.